Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksGLAND
resources
GLAND
3,074.50+25.5 (+0.84%)
29 Oct, 12:00 AM

Annual Reports and Financial Documents

Gland Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Gland Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General23 Oct 2026
    Conclusion Of USFDA Unannounced Inspection At Company''s Formulation Facility At Dundigal, Hyderabad
    Conclusion of USFDA Unannounced Inspection at Company''s Formulation Facility at Dundigal, Hyderabad
  2. Analyst / Investor Meet21 Oct 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Q2FY27 Earnings Call Intimation
  3. Board Meeting21 Oct 2026
    Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026
    Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....
  4. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201812 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Reg 74(5) of the SEBI (DP) Regulations, 2018
  5. Newspaper Publication7 Oct 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication regarding the dipatch of Notice of Postal Ballot
  6. Postal Ballot6 Oct 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Postal Ballot Notice
  7. Change in Directorate1 Oct 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Resignation of Mr. Wenjie Zhang as a Non-Executive & Non-Independent Director and Appointment of Mr. Xingli Wang as an Additional Director (Non-Executive and Non-Independent Director)
  8. Acquisition1 Oct 2026
    Announcement under Regulation 30 (LODR)-Updates on Acquisition
    Investment by Gland Pharma Limited in Gland Pharma USA Inc. and Investment by Gland Pharma USA Inc. into Novelstar Pharma Inc.
  9. Outcome without intimation1 Oct 2026
    Board Meeting Outcome for Outcome Of Board Meeting - 01-10-2026
    Outcome of Board Meeting held on October 01, 2026
  10. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20111 Oct 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fosun Pharma Industrial Pte Ltd
  11. Closure of Trading Window30 Sept 2026
    Closure of Trading Window
    Closure of Trading Window
  12. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201130 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
  13. Newspaper Publication29 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of Newspaper Publication
  14. Acquisition13 Sept 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Acquisition of Gland Pharma USA Inc., a wholly-owned Step down subsidiary from Gland Pharma International Pte. Ltd, a wholly-owned subsidiary of the Company
  15. Outcome without intimation13 Sept 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board Meeting
  16. Allotment of ESOP / ESPS13 Sept 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Allotment of 44,193 Equity Shares on exercise of ESOPs
  17. General13 Sept 2026
    Grant Of Stock Options Under Gland Pharma Employee Stock Option Scheme, 2025
    Grant of Stock Options under Gland Pharma Employee Stock Option Scheme, 2025
  18. General13 Sept 2026
    Board Comments On Fines Levied By Exchanges
    Board Comments on fines levied by Exchanges
  19. Analyst / Investor Meet10 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Schedule of Investor Meetings
  20. Analyst / Investor Meet8 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Investor Meet Intimation

Frequently Asked Questions

Where can I download the annual report of Gland Pharma Ltd.?
Annual reports of Gland Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Gland Pharma Ltd.?
Quarterly earnings results and presentations of Gland Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Gland Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Gland Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Gland Pharma Ltd.?
Investor presentations and annual day presentations of Gland Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Gland Pharma Ltd.?
Corporate announcements and regulatory filings of Gland Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Gland Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Gland Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Gland Pharma Ltd.?
The ISIN (International Securities Identification Number) of Gland Pharma Ltd. is INE068V01023. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Gland Pharma Ltd. listed?
Gland Pharma Ltd. is listed on NSE and BSE. The NSE symbol is GLAND and the BSE code is -.
Where can I find the shareholding pattern of Gland Pharma Ltd.?
The quarterly shareholding pattern of Gland Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Gland Pharma Ltd. on Sharpely?
Share price data for Gland Pharma Ltd. is updated as of 29 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.